|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes显示文摘 | P. V. H?jberg T. Vilsb?ll R. Rab?l F. K. Knop M. Bache T. Krarup J. J. Holst S. Madsbad | 2009 | Diabetologia2009，，2： | 1 |
| 2 | One-daily human Glp-1 analog liraglutide reduces systoic blood pressure-a meta analysis of six dinical trials(LEAD)显示文摘 | Fonseca V Madsbad S Falahati A | 2009 | Diabetes2009，58，1： | 1 |
| 3 | Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study 显示文摘 | Zander M Madsbad S Madsen JL | 2002 | Lancet2002，359，： | 1 |
| 4 | Antidiabetic action of endogenous and exogenous GLP-l in type 1 diabetic patients with and without residual beta-cell funclion显示文摘 | Kielgast U Holst JJ Madsbad S | 2011 | Diabetes2011，60，5： | 1 |
| 5 | Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials 显示文摘 | MADSBAD S KRARUP T DEACON C F | 2008 | Curr Opin Clin Nutr Metab Care2008，11，4： | 1 |
| 6 | Continuous subcutaneous infusion of glucagon - like peptide 1 low- ers plasma glucose and reduces appetite in type 2 diabetic patients 显示文摘 | Tort - Nielsen MB Madsbad S Holst JJ | 1999 | Diabetes Care1999，22，： | 1 |
| 7 | Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients显示文摘 | Tort-Nielsen MB Damhoit MB Madsbad S | 2001 | Clin Endocrinol Metab2001，86，： | 1 |
| 8 | The effect of tesofensine on body weight and body composition in obese subjects-secondary publication显示文摘 | Nielsen AL Larsen TM Madsbad S | | 0，，41： | 1 |
| 9 | Once-daily human GLP-1 analog liraglutide reduces systolic blood pressure-a-meta-analysis of six clinical trials(LEAD)显示文摘 | Fonseca V Madsbad S Falahati A | 2009 | Diabetes2009，58，1： | 1 |
| 10 | Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients 显示文摘 | Toft-Nielsen MB Damholt MB Madsbad S | 2001 | J Clin Endo- crinol Metab2001，86，8： | 1 |
| 11 | Improved gXycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-actingglucagon-like peptide lanalog liraglutide (NN2211): A 12- week, double-blind, randomized, controlled trial显示文摘 | Madsbad S Schmitz O Ranstam J | 2004 | Diabetes Care2004，27，6： | 1 |
| 12 | Determi- nants of the impaired secretion of glucagon- like peptide- 1 in type 2 diabetic patients 显示文摘 | Toft-Nielsen MB Damholt MB Madsbad S | 2001 | J Glln Endocrinol Metab2001，86，6： | 1 |
| 13 | Effect of 6-week course of glucagon-like peptide 1 on glycaemic control,in sulin sensitivity,and beta-cell function in type 2 diabetes:a parallelgroup study显示文摘 | Zander M Madsbad S Madsen J L | 2002 | Lancet2002，359，： | 1 |
| 14 | Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function显示文摘 | Kielgast U Hoist J J Madsbad S | 2011 | Diabetes2011，60，： | 1 |
| 15 | GLP-I: physiological effects and potential therapeutic applications 显示文摘 | AABOE K KRARUP T MADSBAD S ' | 2008 | DiabetesObesMetab2008，10，1： | 1 |
| 16 | Eeffect of 6week course of glucangon-like peptide 1 on glacamic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study显示文摘 | Zander M Madsbad S Madse JL | 2002 | Lancet2002，359，： | 1 |
| 17 | Defective amplification of the late phase insulin response to glu- cose by GIP in obese type II diabetic patients显示文摘 | Vilsboll T Krarup T Madsbad S | 2002 | Di- abetologia2002，45，8： | 1 |
| 18 | Improved glycemic control with no weight increase in patients with type 2 diabetes after oncedaily treatment with the long-acting glucagon-like peptide 1 analog liraglutide(NN2211):a 12-week,doable-blind,randomized,controlled trial显示文摘 | Madsbad S Schmitz O Banstam J | 2004 | Diabetes Care2004，27，6： | 1 |
| 19 | Effect of 6-week course of glucagon-like peptide 1 on glycaemic control,insulin sensitivity,and beta cell function in type 2 diabetes:a parallel group study显示文摘 | Zer M Madsbad S Madsen JL | 2002 | Lancet2002，359，： | 1 |
| 20 | Comparisonof the soluble basal insulin analog insulin detemir with NPHinsulin : a randomized open crossover trial in type 1 diabeticsubjects on basal-bolus therapy显示文摘 | HERMANSEN K MADSBAD S PERRILD H | 2001 | Diabetes Care2001，24，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员